514 related articles for article (PubMed ID: 18545747)
1. [Specificities of patent protection in the pharmaceutical industry: modalities and traits of intellectual property].
Jannuzzi AH; Vasconcellos AG; de Souza CG
Cad Saude Publica; 2008 Jun; 24(6):1205-18. PubMed ID: 18545747
[TBL] [Abstract][Full Text] [Related]
2. Patent law protection of inventions in medicine and pharmaceutical industry.
Miladinović Z; Varga S; Radojković M
Vojnosanit Pregl; 2013 Jun; 70(6):600-5. PubMed ID: 23885528
[No Abstract] [Full Text] [Related]
3. Enforcing pharmaceutical and biotech patent rights in China.
Zhang YP; Deng MM
Nat Biotechnol; 2008 Nov; 26(11):1235-40. PubMed ID: 18997760
[No Abstract] [Full Text] [Related]
4. Enabling policy planning and innovation management through patent information and co-authorship network analyses: a study of tuberculosis in Brazil.
Vasconcellos AG; Morel CM
PLoS One; 2012; 7(10):e45569. PubMed ID: 23056208
[TBL] [Abstract][Full Text] [Related]
5. Analyzing the protection scope limit for biosequence patent claims in China.
Li W
Nat Biotechnol; 2018 Sep; 36(9):811-813. PubMed ID: 30188533
[No Abstract] [Full Text] [Related]
6. [Evolution of the international intellectual property rights system: patent protection for the pharmaceutical industry and access to medicines].
Chaves GC; Oliveira MA; Hasenclever L; de Melo LM
Cad Saude Publica; 2007 Feb; 23(2):257-67. PubMed ID: 17221075
[TBL] [Abstract][Full Text] [Related]
7. Using the written description requirement to limit broad patent scope, allow competition, and encourage innovation in biotechnology.
Mull WC
Health Matrix Clevel; 2004; 14(2):393-435. PubMed ID: 15503695
[TBL] [Abstract][Full Text] [Related]
8. Intellectual property protection of plant biotechnology inventions.
Sechley KA; Schroeder H
Trends Biotechnol; 2002 Nov; 20(11):456-61. PubMed ID: 12413819
[TBL] [Abstract][Full Text] [Related]
9. Has the implementation of the TRIPS Agreement in Latin America and the Caribbean produced intellectual property legislation that favours public health?
Oliveira MA; Bermudez JA; Chaves GC; Velásquez G
Bull World Health Organ; 2004 Nov; 82(11):815-21. PubMed ID: 15640916
[TBL] [Abstract][Full Text] [Related]
10. Research on the pharmaceutical intellectual property protection and supervision of pharmacy administration.
Xu Z; Chen W
Pak J Pharm Sci; 2017 May; 30(3(Special)):1081-1087. PubMed ID: 28671085
[TBL] [Abstract][Full Text] [Related]
11. Revitalizing the patent system to incentivize pharmaceutical innovation: the potential of claims with means-plus-function clauses.
Tang WL
Duke Law J; 2013 Feb; 62(5):1069-108. PubMed ID: 25330553
[TBL] [Abstract][Full Text] [Related]
12. Patent first, ask questions later: morality and biotechnology in patent law.
Bagley MA
William Mary Law Rev; 2003 Dec; 45(2):469-547. PubMed ID: 15570677
[TBL] [Abstract][Full Text] [Related]
13. Patenting pharmaceuticals in China.
Han W; Luo J
Pharm Pat Anal; 2016 Jul; 5(4):249-59. PubMed ID: 27338759
[TBL] [Abstract][Full Text] [Related]
14. [Patents on life? No patent on life!].
van Raden L
Dtsch Tierarztl Wochenschr; 1998 Mar; 105(3):90-3. PubMed ID: 9581373
[TBL] [Abstract][Full Text] [Related]
15. Ownership of knowledge--the role of patents in pharmaceutical R&D.
Correa CM
Bull World Health Organ; 2004 Oct; 82(10):784-7; discussion 787-90. PubMed ID: 15643801
[TBL] [Abstract][Full Text] [Related]
16. Patent implications in the pharmaceutical industry: Are static high prices leading to dynamic innovations?
Pandey E; Paul SB
Int J Risk Saf Med; 2019; 30(3):179-192. PubMed ID: 31450515
[TBL] [Abstract][Full Text] [Related]
17. Impact of the World Trade Organization TRIPS agreement on the pharmaceutical industry in Thailand.
Supakankunti S; Janjaroen WS; Tangphao O; Ratanawijitrasin S; Kraipornsak P; Pradithavanij P
Bull World Health Organ; 2001; 79(5):461-70. PubMed ID: 11417042
[TBL] [Abstract][Full Text] [Related]
18. "Obvious to try": a proper patentability standard in the pharmaceutical arts?
Trask AV
Fordham Law Rev; 2008 Apr; 76(5):2625-68. PubMed ID: 18546581
[No Abstract] [Full Text] [Related]
19. Intellectual property policy in the pharmaceutical sciences: the effect of inappropriate patents and market exclusivity extensions on the health care system.
Kesselheim AS
AAPS J; 2007 Aug; 9(3):E306-11. PubMed ID: 17915832
[TBL] [Abstract][Full Text] [Related]
20. Asserting the primacy of health over patent rights: a comparative study of the processes that led to the use of compulsory licensing in Thailand and Brazil.
Rosenberg ST
Dev World Bioeth; 2014 Aug; 14(2):83-91. PubMed ID: 24750542
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
